Dr. Ivana Tadić
Work Address
Innrain 52a, Floor 6, 6020 Innsbruck
Office hours: any time by appointment.
please register by email
Mail: ivana.tadic@uibk.ac.at
Telephone: +43 512 507 58883
Areas of Interest:
My primary research interests are use of anticholinergic medications in older adults, health outcomes research and pharmacoeconomics and pharmacy practice research.
Teaching:
- Physiologie und Pathophysiologie II (Niere und Haut), Bachelorstudium
- Wissenschaftliches Schreiben und Statistik, Masterstudium
- Arzneitherapie und Medikationsmanagement, Masterstudium
- Abfassung von wissenschaftlichen Arbeiten, Doktoratsstudium
- Statistik, Doktoratsstudium
Professional Experience:
2023 – now Postdoctoral research fellow, Clinical Pharmacy, University of Innsbruck, Austria
2019 – 2023 Head of the Centre for Pharmacy Practice Development, University of Belgrade – Faculty of Pharmacy, Serbia
2018 – 2024 Associate Professor, University of Belgrade – Faculty of Pharmacy, Serbia
2013 – 2018 Assistant Professor, University of Belgrade – Faculty of Pharmacy, Serbia
2007 – 2013 Research/Teaching Assistant, University of Belgrade – Faculty of Pharmacy, Serbia
2005 – 2027 Pharmacist, Community Pharmacy, Belgrade, Serbia
External Academic Consultancy & Professional Practice:
2022 – now Pharmaceutical Care Network Europe (PCNE), Chairperson
2024 – now member of the General Committee, European Society of Clinical Pharmacy (ESCP)
2024 – now member of the Educational Committee, European Society of Clinical Pharmacy (ESCP)
2019 – now Member of the Pharmaceutical Chamber of Serbia WGs for development of cognitive pharmacy services
Academic Degrees:
2012 Doctoral degree, University of Belgrade – Faculty of Pharmacy, Serbia
2011 One-year postgraduate program at the University of Belgrade – Faculty of Pharmacy, Serbia (study program: Pharmacoeconomics and Pharmaceutical Legislation)
2007 One-year postgraduate program at the University of Belgrade – Faculty of Pharmacy, Serbia (study program: Pharmaceutical Management and Marketing)
1997 – 2005 Master degree at the University of Belgrade – Faculty of Pharmacy, Belgrade, Serbia
Internationally Funded Research Collaboration:
2020 – 2024 COST (European cooperation in Science & Technology) Action CA19132, European Network to Advance Best practice & technology on medication adherence (ENABLE)
2020 – 2024 COST (European cooperation in Science & Technology) Action CA19113: “The European Researchers' Network Working on Second Victims”
2020 – 2021 Republic of Serbia, Innovation Found, Proof of Concept Program “Pharmaceutical care service for diabetic patients – development of e-portal and mobile app as supporting concept based on the users’ needs”
2019 – 2023 Project of the Serbian Ministry of Education, Science and Technological Development, Grant no. 451-03-68/2020-14/200161
2017 – 2018 erasmus+ Programme, European Commission “Reinforcement of the Framework for Experiential Education in Healthcare in Serbia (ReFEEHS)”
Research publications
Research In Preparation
- Current practices on prescribing and deprescribing for patients on long-term antibiotic treatment for chronic pulmonary conditions - An umbrella review by the European Society of Clinical Pharmacy (ESCP)
- Tadic I, Weidmann AE. Anticholinergic medicines and their potential in anticholinergic burden
- The quality of reporting economic evaluations of medication reconciliation and medication review interventions at different stages of hospitalization provided by pharmacists
Research Publications
- Tadić I, Schintler J, Weidmann AE. Implications of a pharmacy students' involvement in collecting the best possible medication histories in hospital settings: a scoping review. American Journal of Health-System Pharmacy, 2025; zxaf101, https://doi.org/10.1093/ajhp/zxaf101
- Weidmann AE, Proppé GB, Matthíasdóttir R, Tadić I, Gunnarsson PS, Jónsdóttir F. Medication-induced causes of delirium in patients with and without dementia: a systematic review of published neurology guidelines. Int J Clin Pharm. 2025. doi: 10.1007/s11096-024-01861-4. Epub ahead of print. PMID: 39969659.
- Seitaridou Y, Grega D, Paveliu S, Männik A, Holko P, Tadić I, Stevic I, Chamova T, Petrova G, KamushevaM. Access to Medicines, Care, and Services for Multiple Sclerosis Patients in Central and Eastern European Countries: A Comparative Analysis. Expert Review of Pharmacoeconomics and Outcomes Research. Accepted
- Dima A L, Nabergoj Makovec U, Ribaut J, Haupenthal F, Barnestein-Fonseca P, Goetzinger C, Grant SP, Smits D, Tadic I, van Boven J, Tsiligianni I, Herdeiro MT, Roque F. Stakeholder Consensus on an Interdisciplinary Terminology to Enable the Development and Uptake of Medication Adherence Technologies Across Health Systems: Web-Based Real-Time Delphi Study. JMIR Publications. Accepted
- Jovanović A, Drobac M, Vidović B, Krajnović D, Pavlović D, Tadić I. Treatment of urinary tract infections: study on patients’ beliefs and attitudes. Farmacia. 2025; 73(1):247-54.
- Senćanski D, Tadić I, Jocić D, Marinković V. Perceived importance of emotional intelligence for clinical pharmacy practice and suggested improvements: a focus group study of postgraduate pharmacists. Int J Clin Pharm. 2024;46(5):1152-1162. doi: 10.1007/s11096-024-01748-4. Epub 2024. PMID: 38861045.